Live Breaking News & Updates on Screen printed innovative drug

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

BioPharma

San-diego , California , United-states , Helmut-kerschbaumer , Achim-schneeberger , Laxxon-medical-announces-development-program-for-non , Medical-announces-development-program , Printed-oral , Laxxon-medical , Screen-printed-innovative-drug , Chief-scientific

Laxxon Medical: Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

Laxxon Medical: Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New-york , United-states , San-diego , California , Frances-hoggard , Jessica-mchargue , Helmut-kerschbaumer , Alexander-ruckdaeschel , Achim-schneeberger , Business-development-contact , Business-development , Laxxon-medical-announces-development-program-for-non

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

Using their SPID®-Technology, Laxxon Medical has manufactured a 3D printed oral tablet combining a GLP-1 receptor agonist and a permeation enhancer intended to increase bioavailabilityLXM.2 is being developed

San-diego , California , United-states , Alexander-ruckdaeschel , Helmut-kerschbaumer , Jessica-mchargue , Frances-hoggard , Achim-schneeberger , Business-development , Business-development-contact , Laxxon-medical , Screen-printed-innovative-drug